Tag: #her2

Articles related to her2

health

FDA OKs Pfizer’s TUKYSA for Front‑line Maintenance in HER2‑Positive Metastatic Breast Cancer

FDA expands Pfizer's TUKYSA for front‑line maintenance in unresectable/metastatic HER2‑positive breast cancer; PFS improved 8.6 months, liver risks noted.

$PFE, #her2, #breastcancer, #pfizer, #fda